Literature DB >> 20203644

Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors?

Jessica A Davila.   

Abstract

Known risk factors for hepatocellular carcinoma (HCC) include hepatitis C, hepatitis B, and alcoholic liver disease. Several studies have examined diabetes as a risk factor for HCC because of its association with fatty liver disease and non-alcoholic steatohepatitis. The current study by Tung et al. found that neither diabetes nor overweight was a risk factor for HCC. Results were consistent using both a cross-sectional and a case-control study approach. Findings from this study suggest that diabetes and overweight alone are not adequate to increase the risk of HCC in the absence of concomitant viral hepatitis or liver disease.

Entities:  

Mesh:

Year:  2010        PMID: 20203644     DOI: 10.1038/ajg.2009.715

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

2.  Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women.

Authors:  Juhua Luo; Rowan Chlebowski; Simin Liu; Katherine A McGlynn; Niyati Parekh; Donna L White; Karen L Margolis
Journal:  Cancer Causes Control       Date:  2012-05-24       Impact factor: 2.506

3.  Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.

Authors:  M Sarkar; S Stewart; A Yu; M S Chen; T T Nguyen; M Khalili
Journal:  J Viral Hepat       Date:  2012-01-28       Impact factor: 3.728

4.  Gene expression profiling of liver cancer stem cells by RNA-sequencing.

Authors:  David W Y Ho; Zhen Fan Yang; Kang Yi; Chi Tat Lam; Michael N P Ng; Wan Ching Yu; Joyce Lau; Timothy Wan; Xiaoqi Wang; Zhixiang Yan; Hang Liu; Yong Zhang; Sheung Tat Fan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

5.  Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells.

Authors:  Yue Zhang; Ruijiao Chang; Muqiong Li; Kun Zhao; Hongzhi Zheng; Xiaodong Zhou
Journal:  Onco Targets Ther       Date:  2016-08-01       Impact factor: 4.147

Review 6.  Nonalcoholic fatty liver disease: Evolving paradigms.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Mauro Maurantonio; Alessandra Marrazzo; Luca Rinaldi; Luigi Elio Adinolfi
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

7.  Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.

Authors:  Yvonne N Flores; Zuo-Feng Zhang; Roshan Bastani; Mei Leng; Catherine M Crespi; Paula Ramírez-Palacios; Heather Stevens; Jorge Salmerón
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.